Takimoto Chris H — SEC Form 4 filings
SEC reporting owner CIK 1743780. 7 Form 4 filings on record with FilingPulse; latest filed 2026-01-21.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-03-14 to 2026-01-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 3 filings — 8,481 shares, $83,363 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: sale of 2,889 shares @ $9.88 ($28,529) in IGM Biosciences, Inc., filed 2024-03-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| IGM Biosciences, Inc. (IGMS) | CHIEF MEDICAL OFFICER | 5 | — | 4 legs · 8,481 sh · $83,363 | 6 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | Director | 2 | — | — | 2 |
Form 4 filings — Takimoto Chris H
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-21 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 40,400 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 40,400 (derivative) @ $0 | EDGAR |
| 2024-09-17 | 4 | IGM Biosciences, Inc. (IGMS) | Sale (S): 1,487 @ $11.54 | EDGAR |
| 2024-07-23 | 4 | IGM Biosciences, Inc. (IGMS) | Grant/award (A): 43,750 · Grant/award (A): 16,250 · Disposition to issuer (D): 150,000 (derivative) | EDGAR |
| 2024-06-18 | 4 | IGM Biosciences, Inc. (IGMS) | Grant/award (A): 3,000 @ $5.02 · Sale (S): 1,570 @ $7.58 | EDGAR |
| 2024-03-15 | 4 | IGM Biosciences, Inc. (IGMS) | Sale (S): 2,889 @ $9.88 · Sale (S): 2,535 @ $10.17 | EDGAR |
| 2024-03-14 | 4 | IGM Biosciences, Inc. (IGMS) | Grant/award (A): 46,250 @ $0 · Grant/award (A): 92,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1743780 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →